Canadian Manufacturing

Rodo Medical and Aurum Group enter joint venture agreement

by CM Staff   

Financing Manufacturing Supply Chain dental prosthetics manufacturing


RDP will combine capabilities from each company to offer dentists digitally enhanced prosthetic solutions SmileLoc, SmileClip and SmileKey.

CALGARY — RODO Medical and The Aurum Group have entered a strategic partnership to launch Rodo Digital Prosthetics in the U.S. RDP will be a new dental laboratory combining RODO’s proprietary technologies with Aurum’s Core3dcentres.

Core3dcentres is a wholly owned subsidiary of Aurum and is a provider of manufacturing and servicing of dental protheses.

The company stated that Mike Girard, who currently serves as President of Aurum will also serve as President of RDP. Mr. Girard has over 40 years of experience launching and building successful digital companies in dentistry including Nobel Procura, Brontes Technologies and Diadem Precision Technologies.

Under Mr. Girard’s leadership, RDP will combine capabilities from each company to offer dentists digitally enhanced prosthetic solutions SmileLoc, SmileClip and SmileKey.

Advertisement

According to the company, the SmileClip solution will close the gap between traditional denture and implant-fixed denture while providing treatment options to over 35 million edentulous people in North America. RODO products will be available in 2022 to select RODO users and Aurum customers.

In addition, both companies have agreed to a limited exclusive distribution agreement in Canada. Aurum will be able to service RODO’s Smileloc and Smileclip restorations for their customers from single crown to full mouth with their prostheses across the country.

“We are extremely proud to welcome RODO as our strategic partner across North America and look forward to integrating their highly innovative and unique technology into our offerings to provide our customers with complete integrated prosthetic solutions. RODO’s proprietary product suite dramatically improves the quality of patient care, reduces the risk of perio-implatitis, improves prosthetic integrity & retrievability all while improving clinical efficiency. Together, RODO and Aurum are positioned to address a tremendous opportunity for advanced care in the edentulous market,” said Aurum Group’s CEO Mark Maier in a statement.

 

Advertisement

Stories continue below